Literature DB >> 20084034

Ex vivo transfer of the Hoxc-8-interacting domain of Smad1 by a tropism-modified adenoviral vector results in efficient bone formation in a rabbit model of spinal fusion.

Joanne T Douglas1, Angel A Rivera, Gray R Lyons, Patricia F Lott, Dezhi Wang, Majd Zayzafoon, Gene P Siegal, Xu Cao, Steven M Theiss.   

Abstract

STUDY
DESIGN: Ex vivo gene transfer for spinal fusion.
OBJECTIVE: This study aimed to evaluate ex vivo transfer of the nuclear-localized Hoxc-8-interacting domain of Smad1 (termed Smad1C) to rabbit bone marrow stromal cells (BMSCs) by a tropism-modified human adenovirus serotype 5 (Ad5) vector as a novel therapeutic approach for spinal fusion. SUMMARY OF BACKGROUND DATA: Novel approaches are needed to improve the success of bone union after spinal fusion. One such approach is the ex vivo transfer of a gene encoding an osteoinductive factor to BMSCs which are subsequently reimplanted into the host. We have previously shown that heterologous expression of the Hoxc-8-interacting domain of Smad1 in the nuclei of osteoblast precursor cells is able to stimulate the expression of genes related to osteoblast differentiation and induce osteogenesis in vivo. Gene delivery vehicles based on human Ad5 are well suited for gene transfer for spinal fusion because they can mediate high-level, short-term gene expression. However, Ad5-based vectors with native tropism poorly transduce BMSCs, necessitating the use of vectors with modified tropism to achieve efficient gene transfer.
METHODS: The gene encoding Smad1C was transferred to rabbit BMSCs by an Ad5 vector with native tropism or a vector retargeted to alphav integrins, which are abundantly expressed on rabbit BMSCs. Transduced BMSCs were maintained in osteoblastic differentiation medium for 30 days. Alkaline phosphatase activity was determined and cells stained for calcium deposition. As positive controls for osteogenesis, we used Ad5 vectors expressing bone morphogenetic protein 2. As negative controls, BMSCs were mock-transduced or transduced with an Ad5 vector expressing beta-galactosidase. In an immunocompetent rabbit model of spinal fusion, transduced BMSCs were coated onto absorbable gelatin sponge and implanted between decorticated transverse processes L6 and L7 of 8-week-old female New Zealand white rabbits. Animals were killed 4 weeks after implantation of the sponges, the fusion masses harvested and the area of new bone quantified using image analysis software.
RESULTS: The Smad1C-expressing tropism-modified Ad5 vector mediated a significantly higher level of alkaline phosphatase activity and calcium deposition in transduced rabbit BMSCs than all other vectors. The rabbit BMSCs transduced ex vivo with the Smad1C-expressing tropism-modified Ad5 vector mediated a greater amount of new bone formation than BMSCs transduced with any other vector.
CONCLUSIONS: Delivery of the Smad1C gene construct to BMSCs by an alphav integrin-targeted Ad5 vector shows promise for spinal fusion and other applications requiring the formation of new bone in vivo.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20084034      PMCID: PMC2819464          DOI: 10.1097/BSD.0b013e318193b693

Source DB:  PubMed          Journal:  J Spinal Disord Tech        ISSN: 1536-0652


  43 in total

Review 1.  Osteoinductive bone graft substitutes.

Authors:  S C Ludwig; J M Kowalski; S D Boden
Journal:  Eur Spine J       Date:  2000-02       Impact factor: 3.134

Review 2.  Delivering on the promise of bone morphogenetic proteins.

Authors:  R H Li; J M Wozney
Journal:  Trends Biotechnol       Date:  2001-07       Impact factor: 19.536

Review 3.  Targeted adenoviral vectors.

Authors:  Brian G Barnett; C Jefferson Crews; Joanne T Douglas
Journal:  Biochim Biophys Acta       Date:  2002-05-03

Review 4.  Gene transfer approaches to the healing of bone and cartilage.

Authors:  Jay R Lieberman; Steven C Ghivizzani; Christopher H Evans
Journal:  Mol Ther       Date:  2002-08       Impact factor: 11.454

5.  Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions.

Authors:  G E Friedlaender; C R Perry; J D Cole; S D Cook; G Cierny; G F Muschler; G A Zych; J H Calhoun; A J LaForte; S Yin
Journal:  J Bone Joint Surg Am       Date:  2001       Impact factor: 5.284

6.  Smad1 domains interacting with Hoxc-8 induce osteoblast differentiation.

Authors:  X Yang; X Ji; X Shi; X Cao
Journal:  J Biol Chem       Date:  2000-01-14       Impact factor: 5.157

7.  The effect of nicotine on gene expression during spine fusion.

Authors:  S M Theiss; S D Boden; G Hair; L Titus; M A Morone; J Ugbo
Journal:  Spine (Phila Pa 1976)       Date:  2000-10-15       Impact factor: 3.468

8.  Use of a chimeric adenovirus vector enhances BMP2 production and bone formation.

Authors:  Elizabeth A Olmsted-Davis; Zbigniew Gugala; Francis H Gannon; Patricia Yotnda; Robert E McAlhany; Ronald W Lindsey; Alan R Davis
Journal:  Hum Gene Ther       Date:  2002-07-20       Impact factor: 5.695

9.  The therapeutic efficacy of adenoviral vectors for cancer gene therapy is limited by a low level of primary adenovirus receptors on tumour cells.

Authors:  M Kim; K R Zinn; B G Barnett; L A Sumerel; V Krasnykh; D T Curiel; J T Douglas
Journal:  Eur J Cancer       Date:  2002-09       Impact factor: 9.162

10.  An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism.

Authors:  I Dmitriev; V Krasnykh; C R Miller; M Wang; E Kashentseva; G Mikheeva; N Belousova; D T Curiel
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

View more
  4 in total

Review 1.  Spinal fusion in the next generation: gene and cell therapy approaches.

Authors:  Marta Barba; Claudia Cicione; Camilla Bernardini; Vincenzo Campana; Ernesto Pagano; Fabrizio Michetti; Giandomenico Logroscino; Wanda Lattanzi
Journal:  ScientificWorldJournal       Date:  2014-01-28

Review 2.  Mesenchymal Stem Cells for the Treatment of Spinal Arthrodesis: From Preclinical Research to Clinical Scenario.

Authors:  F Salamanna; M Sartori; G Barbanti Brodano; C Griffoni; L Martini; S Boriani; M Fini
Journal:  Stem Cells Int       Date:  2017-02-13       Impact factor: 5.443

Review 3.  The Biological Enhancement of Spinal Fusion for Spinal Degenerative Disease.

Authors:  Takahiro Makino; Hiroyuki Tsukazaki; Yuichiro Ukon; Daisuke Tateiwa; Hideki Yoshikawa; Takashi Kaito
Journal:  Int J Mol Sci       Date:  2018-08-17       Impact factor: 5.923

4.  Clinical and radiological outcomes of a cervical cage with integrated fixation.

Authors:  Nicolas Lonjon; Emmanuel Favreul; Jean Huppert; Eric Lioret; Manuel Delhaye; Ramzi Mraidi
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.